CYTOMX THERAPEUTICS INC's ticker is CTMX and the CUSIP is 23284F105. A total of 111 filers reported holding CYTOMX THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 1.49 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $26,901 | -43.2% | 17,815 | -39.8% | 0.01% | -40.0% |
| Q4 2022 | $47,323 | -27.2% | 29,577 | -34.1% | 0.01% | -37.5% |
| Q3 2022 | $65,000 | -64.7% | 44,848 | -55.4% | 0.02% | -78.7% |
| Q2 2022 | $184,000 | -41.8% | 100,604 | -15.0% | 0.08% | -46.0% |
| Q1 2022 | $316,000 | +618.2% | 118,339 | +1064.2% | 0.14% | +456.0% |
| Q4 2021 | $44,000 | -67.6% | 10,165 | -52.5% | 0.02% | -45.7% |
| Q2 2021 | $136,000 | – | 21,422 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,500,000 | $7,635,000 | 1.78% |
| Altium Capital Management LP | 1,233,642 | $6,279,000 | 1.65% |
| RA Capital Management | 3,500,000 | $17,815,000 | 0.25% |
| Soleus Capital Management, L.P. | 261,050 | $1,329,000 | 0.21% |
| Affinity Asset Advisors, LLC | 125,000 | $636,000 | 0.16% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 1,078,103 | $5,488,000 | 0.16% |
| Point72 Asset Management, L.P. | 6,303,025 | $32,082,000 | 0.14% |
| GSA CAPITAL PARTNERS LLP | 249,146 | $1,268,000 | 0.13% |
| Candriam S.C.A. | 3,305,940 | $16,826,000 | 0.11% |
| RTW INVESTMENTS, LP | 1,400,939 | $7,131,000 | 0.11% |